Lindsay Mark F. 4 SEC Filings

Filed On	Filing
26 Oct 2026	Form 4: Lindsay Mark F., Director · Vivos Therapeutics Inc Granted 12,000 Stock Options (Right to Buy)
28 Jun 2024	Form 4: Lindsay Mark F., Director · Vivos Therapeutics Inc Granted 4,000 Stock Option (Right to Buy) ($9.52K)
28 Dec 2022	Form 4: Lindsay Mark F., Director · Vivos Therapeutics Inc Granted 30,000 Stock Option (Right to Buy) ($14.4K)
10 Aug 2021	Form 4: Lindsay Mark F., Director · Vivos Therapeutics Inc Granted 30,000 Stock Option (Right to Buy) ($81.6K)

Comments